Quality of care and attributable healthcare costs in diabetic hypertensive patients initiated on calcium antagonist therapy

John J. Barron*, Ibrahim Al-Zakwani, Thomas Iarocci

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Quality of care and attributable healthcare costs in diabetic hypertensive patients initiated on calcium antagonist therapy'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Agricultural and Biological Sciences